Promising Antioxidative Effect of Berberine in Cardiovascular Diseases

Promising Antioxidative Effect of Berberine in Cardiovascular Diseases

Berberine (BBR), an important quaternary benzylisoquinoline alkaloid, has been used in Chinese traditional medicine for over 3,000 years. BBR has been shown in both traditional and modern medicine to have a wide range of pharmacological actions, including hypoglycemic, hypolipidemic, anti-obesity, h...

Full description

Bibliographic Details
Main Authors:	Na An, Guoxia Zhang, Yingjian Li, Chao Yuan, Fan Yang, Lijing Zhang, Yonghong Gao, Yanwei Xing
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Pharmacology
Subjects:	Berberine cardiovascular disease reactive oxygen species coronary atherosclerosis myocardial infarction/reperfusion
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.865353/full

Similar Items

Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
by: Na An, et al.
Published: (2019-07-01)

Cardiomyocyte Damage: Ferroptosis Relation to Ischemia-Reperfusion Injury and Future Treatment Options
by: Jolanta Laukaitiene, et al.
Published: (2023-08-01)

Berberin sustained-release nanoparticles were enriched in infarcted rat myocardium and resolved inflammation
by: Ke Zhu, et al.
Published: (2023-01-01)

ROS-Responsive Berberine Polymeric Micelles Effectively Suppressed the Inflammation of Rheumatoid Arthritis by Targeting Mitochondria
by: Xing-xing Fan, et al.
Published: (2020-03-01)

The Ameliorative Impacts of Berberine on Testicular Ischemia/reperfusion Injury in Rats: An Experimental Study
by: Masoumeh Moradi-Ozarlou, et al.
Published: (2021-05-01)

Simultaneous effect of progesterone and berberine on the level of reactive oxygen species in K562 cell
by: Mohammad Zangooei, et al.
Published: (2023-06-01)

Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b
by: Mo-Li Zhu, et al.
Published: (2017-10-01)

Berberine Protects Against Simulated Ischemia/Reperfusion Injury-Induced H9C2 Cardiomyocytes Apoptosis In Vitro and Myocardial Ischemia/Reperfusion-Induced Apoptosis In Vivo by Regulating the Mitophagy-Mediated HIF-1α/BNIP3 Pathway
by: Na Zhu, et al.
Published: (2020-03-01)

Atheroprotective Effects and Molecular Mechanism of Berberine
by: Lu Xing, et al.
Published: (2021-11-01)

Berberine protects cardiac cells against ferroptosis
by: Kun-Ta Yang, et al.
Published: (2022-01-01)

The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis
by: Richard Y. Cao, et al.
Published: (2021-12-01)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
by: Yun Cai, et al.
Published: (2021-03-01)

Testosterone level in angiographically detected coronary artery disease and myocardial infarction
by: Lajan Qasim Rahman, et al.
Published: (2019-06-01)

Testosterone level in angiographically detected coronary artery disease and myocardial infarction
by: Lajan Qasim Rahman, et al.
Published: (2019-06-01)

Protective effects of berberine on intestinal ischemia and reperfusion injury in rats
by: Chen Tanzhou, et al.
Published: (2017-01-01)

Two Benzene Rings with a Boron Atom Comprise the Core Structure of 2-APB Responsible for the Anti-Oxidative and Protective Effect on the Ischemia/Reperfusion-Induced Rat Heart Injury
by: Yan-Cheng Shen, et al.
Published: (2021-10-01)

The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases
by: Jiahao Zhao, et al.
Published: (2022-12-01)

Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe(−/−) mice
by: Xiaolei Ma, et al.
Published: (2020-09-01)

The mitohormetic response as part of the cytoprotection mechanism of berberine
by: Xiaofei Zhu, et al.
Published: (2020-01-01)

Synthesis and In Vitro Photocytotoxicity of 9-/13-Lipophilic Substituted Berberine Derivatives as Potential Anticancer Agents
by: Hong-Jhih Lin, et al.
Published: (2020-02-01)

Reducing cardiovascular burden in psoriasis patients by using specific therapies – How close are we?
by: Claudia Andreea Palcau, et al.
Published: (2022-09-01)

Comparison of the Incidence of MACCE in Primary Percutaneous Coronary Intervention vs. Delayed Primary Percutaneous Coronary Intervention 24 hours After Taking Fibrinolytic Therapy in Patients with STEMI
by: Nima Naghshtabrizi, et al.
Published: (2019-07-01)

From Q/Non-Q Myocardial Infarction to STEMI/NSTEMI: Why It’s Time to Consider Another Simplified Dichotomy; a Narrative Literature Review
by: Grigorios Avdikos, et al.
Published: (2022-10-01)

The TRPA1 Channel in the Cardiovascular System: Promising Features and Challenges
by: Zhen Wang, et al.
Published: (2019-10-01)

Protective Effects of Curcumin in Cardiovascular Diseases—Impact on Oxidative Stress and Mitochondria
by: Fiona Frederike Cox, et al.
Published: (2022-01-01)

Role of cardiovascular magnetic resonance in the prognosis of patients with myocardial infarction with non-obstructive coronary arteries
by: Nuria Vicente-Ibarra, et al.
Published: (2021-07-01)

Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases
by: Ruojun Li, et al.
Published: (2023-01-01)

Amelioration of testicular damages in renal ischemia/reperfusion by berberine: An experimental study
by: Firouzeh Gholampour, et al.
Published: (2019-11-01)

Ambient Air Pollution Is Associated With the Severity of Coronary Atherosclerosis and Incident Myocardial Infarction in Patients Undergoing Elective Cardiac Evaluation
by: Jaana Hartiala, et al.
Published: (2016-08-01)

Reperfusion therapy for acute myocardial infarction /
by: Bates, Eric R.
Published: (2008)

Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
by: Kook Jin Chun, et al.
Published: (2010-02-01)

Role of Ischemic Preconditioning in the Cardioprotective Mechanisms of Monomeric C-Reactive Protein-Deposited Myocardium in a Rat Model
by: Eun Na Kim, et al.
Published: (2021-02-01)

Cardiovascular risk prediction: a comparative study of Framingham and quantum neural network based approach
by: Narain R, et al.
Published: (2016-07-01)

Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
by: Jawad Mazhar, et al.
Published: (2022-08-01)

Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets
by: Bradley Tucker, et al.
Published: (2021-06-01)

Berberine protects hepatocyte from hypoxia/reoxygenation-induced injury through inhibiting circDNTTIP2
by: Yi Zhu, et al.
Published: (2023-09-01)

Mortality and Cardiovascular Outcomes in Patients Presenting With Non–ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry
by: Gemma A. Figtree, et al.
Published: (2022-08-01)

HELICOBACTER PYLORI AND CARDIOVASCULAR DISEASE: THE ROAD TO THE HEART IS THROUGH THE STOMACH?
by: A. K. Martusevich, et al.
Published: (2012-06-01)

Gender peculiarities of clinical and instrumental indexes in patients with acute Q-wave myocardial infarction after primary coronary intervention
by: Yu. V. Savchenko, et al.
Published: (2021-10-01)

Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
by: Jinluan Chen, et al.
Published: (2023-11-01)